首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation
【24h】

Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation

机译:细胞外RNA构成血液凝固过程中的天然促凝血因子

获取原文
获取原文并翻译 | 示例
           

摘要

Upon vascular injury, locally controlled haemostasis prevents life-threatening blood loss and ensures wound healing. Intracellular material derived from damaged cells at these sites will become exposed to blood components and could contribute to blood coagulation and pathological thrombus formation. So far, the functional and mechanistic consequences of this concept are not understood. Here, we present in vivo and in vitro evidence that different forms of eukaryotic and prokaryotic RNA serve as promoters of blood coagulation. Extracellular RNA was found to augment (auto-)activation of proteases of the contact phase pathway of blood coagulation such as factors Ⅻ and Ⅺ, both exhibiting strong RNA binding. Moreover, administration of exogenous RNA provoked a significant procoagulant response in rabbits. In mice that underwent an arterial thrombosis model, extracellular RNA was found associated with fibrin-rich thrombi, and pretreatment with RNase (but not DNase) significantly delayed occlusive thrombus formation. Thus, extracellular RNA derived from damaged or necrotic cells particularly under pathological conditions or severe tissue damage represents the long sought natural "foreign surface" and provides a procoagulant cofactor template for the factors Ⅻ/Ⅺ-induced contact activation/amplification of blood coagulation. Extracellular RNA thereby reveals a yet unrecognized target for antithrombotic intervention, using RNase or related therapeutic strategies.
机译:发生血管损伤时,局部止血可防止威胁生命的失血并确保伤口愈合。在这些部位源自受损细胞的细胞内物质将暴露于血液中,并可能导致血液凝结和病理性血栓形成。到目前为止,尚不了解此概念的功能和机理后果。在这里,我们提供体内和体外的证据,证明不同形式的真核和原核RNA可以作为凝血的促进剂。发现细胞外RNA增强了凝血接触相途径的蛋白酶(例如因子factors和Ⅺ)的(自)活化,两者都表现出强大的RNA结合。而且,外源RNA的施用在兔子中引起了显着的促凝血反应。在经历了动脉血栓形成模型的小鼠中,发现细胞外RNA与富含纤维蛋白的血栓有关,用RNase(而不是DNase)进行预处理可显着延迟闭塞性血栓的形成。因此,来源于受损或坏死细胞的细胞外RNA,特别是在病理条件下或严重的组织损伤下,代表了人们长期以来寻求的天然“外来表面”,并为凝血因子α/β诱导的接触活化/血液凝固提供了促凝血辅助因子模板。因此,使用RNase或相关治疗策略,细胞外RNA揭示了尚未被认识的抗血栓干预目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号